Edgewise Therapeutics, Inc. (EWTX) vs Indivior Pharmaceuticals Inc (INDV)

A side-by-side comparison of Edgewise Therapeutics, Inc. and Indivior Pharmaceuticals Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — EWTX vs INDV

growth of $100 · dividends reinvested · last 6y
EWTX +34.3% (+5.0%/yr)INDV +318.5% (+26.9%/yr)INDV compounded faster over this window
0100200300400500Start $10020222023202420252026$134$418
EWTX INDV

EWTX vs INDV: by the numbers

  • •INDV is the larger company ($4.44B vs $4.38B market cap).
  • •INDV is profitable (26.65% net margin) while EWTX runs a net loss (0.00%).
  • •INDV pays a dividend (1.32% yield), while EWTX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricEWTXINDV
P/E ratioN/A12.75
Forward P/EN/A8.43
P/S ratioN/A3.33
P/B ratio9.79N/A
EV / EBITDAN/A8.87

Profitability

MetricEWTXINDV
Gross margin0.00%83.86%
Operating margin0.00%21.39%
Net margin0.00%26.65%
ROE-44.02%N/A
ROIC-48.57%N/A

Dividends

MetricEWTXINDV
Dividend yieldN/A1.32%
Payout ratioN/A17.03%

Growth (annualized)

MetricEWTXINDV
Revenue CAGR (5Y)N/A13.88%
Total return CAGR (5Y)16.95%19.65%

Frequently asked

Does EWTX or INDV pay a bigger dividend?
INDV pays a dividend (1.32% yield), while EWTX has no payments in the available dividend history.
Is EWTX or INDV more profitable?
INDV runs the higher net margin — EWTX at 0.00% versus INDV at 26.65%.
How have EWTX and INDV total returns compared?
Over the past 5 years, EWTX delivered 16.95% and INDV delivered 19.65% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.